Associations of insulin resistance and beta-cell function with abnormal lipid profile in newly diagnosed diabetes

被引:2
|
作者
Tang Xiaohan [1 ]
Yan Xiang [1 ]
Zhou Houde [1 ]
Huang Gan [1 ]
Niu Xiaohong [10 ]
Jiang Hongwei [10 ]
Su Heng [10 ]
Yang Xilin [21 ]
Li Xia [1 ]
Zhou Zhiguang [1 ]
机构
[1] Department of Endocrinology
[2] Heji Hospital Affiliated to Changzhi Medical College  12. Changzhi  13. Shanxi 046000  1
[3] Department of Metabolism and Endocrinology
[4] Department of Epidemiology and Biostatistics
[5] School of Public Health  23. Tianjin Medical University  24. Tianjin 300070
[6] National Clinical Research Center for Metabolic Diseases  3. Key Laboratory of Diabetes Immunology (Central South University)  4. Ministry of Ed
基金
国家重点研发计划;
关键词
Beta-cell function; Dyslipidemia; Insulin resistance; Type; 1; diabetes; 2;
D O I
暂无
中图分类号
R587.1 [糖尿病];
学科分类号
1002 ; 100201 ;
摘要
Background: Abnormal lipids are strong predictors of cardiovascular disease in type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). However, the potential associations of insulin resistance (IR) and beta-cell function (BCF) with abnormal lipids in newly diagnosed T1DM or T2DM patients are not fully understood.Methods: A cross-sectional survey of 15,928 participants was conducted. Homeostasis model assessment and postprandial C-peptide levels were used to estimate IR and BCF. A restricted cubic spline (RCS) nested in binary logistic regression was used to examine the associations of IR and BCF with abnormal lipids.Results: High triglyceride (TG), low high-density lipoprotein cholesterol, and high low-density lipoprotein cholesterol (LDL-C) accounted for 49.7%, 47.8%, and 59.2% of the participants, respectively. In multivariable analysis, high IR was associated with an increased risk of high TGs (P for trend <0.001) in T1DM and is associated with an elevated risk of high TG and low HDL-C (allP for trend <0.01) in T2DM. Low BCF was not associated with risks of dyslipidemia in patients with T1DM or T2DM after adjustment for potential confounders.Conclusion: High IR had different associations with the risk of dyslipidemia in newly diagnosed T1DM and T2DM patients, suggesting that early treatment that improves IR may benefit abnormal lipid metabolism.
引用
收藏
相关论文
共 50 条
  • [31] Determinants of insulin resistance and impaired beta-cell function in rheumatoid arthritis
    Dessein, P. H.
    Joffe, B. I.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 146 - 146
  • [32] CIGMA ASSESSMENT OF INSULIN RESISTANCE AND PANCREATIC BETA-CELL FUNCTION IN THE ELDERLY
    DAVIS, TME
    TURNER, RC
    AGE AND AGEING, 1985, 14 (04) : 220 - 224
  • [33] Long-term effect of bezafibrate on pancreatic beta-cell function and insulin resistance in patients with diabetes
    Tenenbaum, Helena
    Behar, Solomon
    Boyko, Valentina
    Adler, Yehuda
    Fisman, Enrique Z.
    Tanne, David
    Lapidot, Mordechai
    Schwarnmenthal, Ehud
    Feinberg, Micha
    Matas, Zipora
    Motro, Michael
    Tenenbaum, Alexander
    ATHEROSCLEROSIS, 2007, 194 (01) : 265 - 271
  • [34] Glycated albumin is correlated to insulin resistance and beta-cell secretory function in subjects at risk of developing diabetes
    Bellia, Chiara
    Zaninotto, Martina
    Cosma, Chiara
    Agnello, Luisa
    Lo Sasso, Bruna
    Altavilla, Patrizia
    Bivona, Giulia
    Pizzolanti, Giuseppe
    Bernardini, Sergio
    Plebani, Mario
    Ciaccio, Marcello
    BIOCHIMICA CLINICA, 2018, 42 (03) : 234 - 239
  • [35] Differences in complication patterns in subgroups of type 2 diabetes according to insulin resistance and beta-cell function
    Yongin Cho
    Seong Ha Seo
    Da Hea Seo
    Seong Hee Ahn
    Seongbin Hong
    Byung Wook Huh
    Yong-ho Lee
    Seok Won Park
    Young Ju Suh
    So Hun Kim
    Scientific Reports, 12
  • [36] Insulin resistance, beta-cell function and glucose homeostasis in schoolchildren in Taiwan
    Tsou, PL
    Jiang, YD
    Chiu, KC
    Chuang, LM
    DIABETES, 2002, 51 : A357 - A357
  • [37] Rosiglitazone decreases insulin resistance and improves beta-cell function in patients with type 2 diabetes.
    Matthews, DR
    Bakst, A
    Weston, WM
    Hemyari, P
    DIABETOLOGIA, 1999, 42 : A228 - A228
  • [38] BETA-CELL FUNCTION IN CHILDREN WITH DIABETES
    LUDVIGSSON, J
    HEDING, LG
    DIABETES, 1978, 27 : 230 - 234
  • [39] Pancreatic Beta-Cell Function, Insulin Sensitivity, and Metabolic Phenotypes in Type 2 Diabetes at the Time of Diagnosis-The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS)
    Dauriz, Marco
    Bonadonna, Riccardo C.
    Trombetta, Maddalena
    Boselli, Linda
    Santi, Lorenza
    Brangani, Corinna
    Pichiri, Isabella
    Bianchi, Cristina
    Miccoli, Roberto
    Del Prato, Stefano
    Bonora, Enzo
    DIABETES, 2015, 64 : A407 - A407
  • [40] RELATIONSHIP BETWEEN BETA-CELL FUNCTION AND ISLET CELL ANTIBODIES IN NEWLY DIAGNOSED ADULT SAUDI DIABETICS
    ALATTAS, OS
    LAAJAM, MA
    KHAN, MS
    ALDRESS, AZ
    BOTTAZZO, GF
    SAUDI MEDICAL JOURNAL, 1991, 12 (02) : 102 - 106